Abstract
The rapidly expanding challenge of antibiotic resistance impacts patients across the globe. Antibiotic-resistant organisms are becoming a massive clinical challenge in the twenty-first century. As outlined in the preceding chapters, all medical practitioners must be aware of the implications of drug resistance when prescribing therapy, as it is becoming very difficult to eradicate infections caused by these antibiotic-resistant pathogens. Pharmaceutical companies do not have vast new drugs in the pipeline. In many ways, we have come to the point as frightening as the preantibiotic era: For patients with multidrug-resistant bacteria, there is no magic bullet.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Todd JK, Todd N, Damato J et al. (1984). Bacteriology and treatment of purulent nasopharyngitis: A double blind placebo-controlled evaluation. Pediatr Infect Dis 3:226–232
Stott NCH, West RR (1976). Randomised controlled trial of antibiotics in patients with cough and purulent sputum. BMJ 6035:556–559
Mainous AG, III, Zoorob RJ, Oler MJ et al. (1997). Patient knowledge of colds: Implications for antibiotic expectations and unnecessary utilization. J Family Pract 45:75–83
Mainous AG, III, Hueston WJ, Eberlein C (1997). Colour of respiratory discharges and antibiotic use. Lancet 350:1077
Ranji SR, Steinman MA, Shojania KG et al. (2008). Interventions to reduce unnecessary antibiotic prescribing: A systematic review and quantitative analysis. Med Care 46:847–862
Roumie CL, Halasa NB, Grijalva CG et al. (2005). Trends in antibiotic prescribing for adults in the United States – 1995 to 2002. J Gen Intern Med 20:697–702
Rubin MA, Bateman K, Donnelly S et al. (2006). Use of a personal digital assistant for managing antibiotic prescribing for outpatient respiratory tract infections in rural communities. J Am Med Inform Assoc 13:627–634
National Vaccine Advisory Committee (1999). Lessons learned from a review of the development of selected vaccines. Pediatrics 104:942–950
MMWR (1998). Progress toward eliminating Haemophilus influenzae type b disease among infants and children – United States, 1987–1997. MMWR Morb Mortal Wkly Rep 47(46):993–998
De Wals P, Erickson L, Poirier B et al. (2009). How to compare the efficacy of conjugate vaccines to prevent acute otitis media?. Vaccine 27:2877–2883
Georgousakis MM, McMillan DJ, Batzloff MR et al. (2009). Moving forward: A mucosal vaccine against group A streptococcus. Expert Rev Vaccines 8:747–760
Arias CA, Murray BE (2009). Antibiotic-resistant bugs in the twenty-first century – A clinical super-challenge. N Engl J Med 360:439–443
Brown EL, Dumitrescu O, Thomas D et al. (2009). The Panton-Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300. Clin Microbiol Infect 15:156–164
Poole K (2003). Overcoming multidrug resistance in gram-negative bacteria. Current Opinion in Investigational. Drugs 4:128–139
Glaser R, Rabin B, Chesney M et al. (1999). Stress induced immunomodulation: Implications for infectious diseases? J Am Med Assoc 281:2268–2270
Grant A, Gothard P, Thwaites G (2008). Managing drug resistant tuberculosis. BMJ 337:a1110
Devaux I, Kremer K, Heersma H et al. (2009). Clusters of multidrug-resistant mycobacterium tuberculosis cases, Europe. Emerg Infect Dis 15:1052–1060
Grigoryan L, Haaijer-Ruskamp FM, Burgerhof JGM et al. (2006). Self-medication with antimicrobial drugs in Europe. Emerg Infect Dis 12:452–459
Drug Utilization Group, Latin America (1997). Multi-center study on self-medication and self-prescription in six Latin American countries. Clin Pharmacol Ther 61:488–493
Hui L, LI XS, Zeng XJ, Dai YH et al. (1997). Patterns and determinants of use of antibiotics for acute respiratory tract infection in children in China. Pediatr Infectious Dis J 16:560–564
Lansang MA, Lucas-Aquino R, Tupasi TE et al. (1990). Purchase of antibiotics without a prescription in Manila, The Philippines. Inappropriate choices and doses. J Clin Epidemiol 43:61–67
Hossain MM, Glass RI, Khan MR (1982). Antibiotic use in a rural community in Bangladesh. Int J Epidemiol 11:402–405
Casner PR, Guerra LG (1992). Purchasing prescription medication in Mexico without a prescription: The experience at the border. West J Med 156:512–516
Mainous AGIII, Cheng AY, Garr RC et al. (2005). Nonprescribed antimicrobial drugs in Latino Community, South Carolina. Emerg Infect Dis 11:883–888
Mainous AGIII, Diaz VA, Carnemolla M (2008). Factors affecting Latino adults’ use of antibiotics for self-medication. J Am Board Fam Med 21:128–134
Mainous AGIII, Everett CJ, Post RE et al. (2009). Availability of antibiotics for purchase without a prescription on the Internet. Ann Fam Med 7(5):431–435
Gilbert P, McBain AJ (2003). Potential impact of increased use of biocides in consumer products on prevalence of antibiotic resistance. Clin Microbiol Rev 16:189–208
Aiello AE, Larson E (2003). Antibacterial cleaning and hygiene products as an emerging risk factor for antibiotic resistance in the community. Lancet Infect Dis 3:501–506
Brooks SE, Walczak MA, Hameed R et al. (2002). Chlorhexidine resistance in antibiotic-resistant bacteria isolated from the surfaces of dispensers of soap containing chlorhexidine. Infect Control Hosp Epidemiol 23:692–695
Aiello AE, Marshall B, Levy SB (2005). Antibacterial cleaning products and drug resistance. Emerg Infect Dis 11:1565–1570
Tan L, Nielsen NH, Young DC et al. (2002). Use of antimicrobial agents in consumer products. Arch Dermatol 138:1082–1086
Wegener HC, Aarestrup FM, Jensen LB et al. (1999). Use of antimicrobial growth promoters in food animals and Enterococcus faecium resistance to therapeutic antimicrobial drugs in Europe. Emerg Infect Dis 5:329–335
Sato K, Bartlett PC, Saeed MA (2005). Antimicrobial susceptibility of Escherichia coli isolates from dairy farms using organic vs conventional production methods. J Am Vet Med Assoc 226:589–594
McDonald CL, Kuehnert MJ, Tenover FC et al. (1997). Vancomycin-resistant enterococci outside the health care setting: Prevalence, sources, and public health. Emerg Infect Dis 3:311–317
Silbergeld EK, Graham J, Price LB (2008). Industrial food production, antimicrobial resistance, and human health. Annu Rev Public Health 29:151–169
Islam M, Doyle MP, Phatak SC et al. (2004). Persistence of enterohemorrhagic Escherichia coli O157:H7 in soil and on leaf lettuce and parsley grown in fields treated with contaminated manure composts or irrigation water. J Food Prot 67:1365–1370
World Health Organization (1997). The medical impact of the use of antimicrobials in food animals. Report from a WHO meeting; Berlin, Germany 1997 Oct 13–17. Geneva:World Health Organization
Commission regulation of amending council directive 70/524/EEC concerning additives in feedingstuffs as regards withdrawal of the authorisation of certain antibiotics (1998). Document No.:VI/7767/98. European Commission, Brussels, Belgium
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Mainous, A.G. (2010). Future Trends in Antimicrobial Use. In: Mainous III, A., Pomeroy, C. (eds) Management of Antimicrobials in Infectious Diseases. Infectious Disease. Humana Press. https://doi.org/10.1007/978-1-60327-239-1_20
Download citation
DOI: https://doi.org/10.1007/978-1-60327-239-1_20
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60327-238-4
Online ISBN: 978-1-60327-239-1
eBook Packages: MedicineMedicine (R0)